Clinical Epidemiology of Buruli Ulcer from Benin (2005-2013): Effect of Time-Delay to Diagnosis on Clinical Forms and Severe Phenotypes

PLoS Neglected Tropical Diseases

Volumn 9, Issue 9, 2015, Pages

  Capela, Carlos ^a,b   Sopoh, Ghislain E ^c,d   Houezo, Jean G ^c   Fiodessihoué, René ^c   Dossou, Ange D ^a,b,c   Costa, Patrício ^a,b   Fraga, Alexandra G ^a,b   Menino, João F ^a,b   Silva Gomes, Rita ^a,b   Ouendo, Edgard M ^d   Rodrigues, Fernando ^a,b   Pedrosa, Jorge ^a,b  

^a UNIVERSITY OF MINHO   (Portugal)

^b UNIVERSITY OF MINHO   (Portugal)

^c Buruli Ulcer Treatment Center of Allada   (Benin)

^d Regional Institute for Public Health   (Benin)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BURULI ULCER; DESCRIPTIVE RESEARCH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MIDDLE AGED; OSTEOMYELITIS; PHENOTYPE; REAL TIME POLYMERASE CHAIN REACTION; SKIN DEFECT; WORLD HEALTH ORGANIZATION; BENIN; CHILD; DELAYED DIAGNOSIS; PATHOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TIME FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; BENIN; BURULI ULCER; CHILD; DELAYED DIAGNOSIS; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; YOUNG ADULT;

EID: 84943174778     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004005     Document Type: Article

References (51)

1. van der Werf TS, Stienstra Y, Johnson RC, Phillips R, Adjei O, et al. (2005) Mycobacterium ulcerans disease. Bull World Health Organ 83: 785–791. 16283056
2. Gama JB, Ohlmeier S, Martins TG, Fraga AG, Sampaio-Marques B, et al. (2014) Proteomic analysis of the action of the Mycobacterium ulcerans toxin mycolactone: targeting host cells cytoskeleton and collagen. PLoS Negl Trop Dis 8: e3066. doi: 10.1371/journal.pntd.0003066 25101965
3. George KM, Chatterjee D, Gunawardana G, Welty D, Hayman J, et al. (1999) Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 283: 854–857. 9933171
4. O'Brien DP, Comte E, Serafini M, Ehounou G, Antierens A, et al. (2013) The urgent need for clinical, diagnostic, and operational research for management of Buruli ulcer in Africa. Lancet Infect Dis 14: 435–440. doi: 10.1016/S1473-3099(13)70201-9 24309480
5. Boleira M, Lupi O, Lehman L, Asiedu KB, Kiszewski AE, (2010) Buruli ulcer. An Bras Dermatol 85: 281–298; quiz 299–301. 20676462
6. Yotsu RR, Nakanaga K, Hoshino Y, Suzuki K, Ishii N, (2012) Buruli ulcer and current situation in Japan: a new emerging cutaneous Mycobacterium infection. J Dermatol 39: 587–593. doi: 10.1111/j.1346-8138.2012.01543.x 22486235
7. O'Brien DP, Jenkin G, Buntine J, Steffen CM, McDonald A, et al. (2014) Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update. Med J Aust 200: 267–270. 24641151
8. Global Health Observatory Data Repositry. Millenium Development Goals 6: Negelected Tropical Diseases [App]. http://apps.who.int/neglected_diseases/ntddata/buruli/buruli.html.
9. Portaels F, Silva MT, Meyers WM, (2009) Buruli ulcer. Clin Dermatol 27: 291–305. doi: 10.1016/j.clindermatol.2008.09.021 19362692
10. Pommelet V, Vincent QB, Ardant MF, Adeye A, Tanase A, et al. (2014) Findings in patients from Benin with osteomyelitis and polymerase chain reaction-confirmed Mycobacterium ulcerans infection. Clin Infect Dis 59: 1256–1264. doi: 10.1093/cid/ciu584 25048846
11. Sopoh GE, Dossou AD, Brun LV, Barogui YT, Houezo JG, et al. (2010) Severe multifocal form of buruli ulcer after streptomycin and rifampin treatment: comments on possible dissemination mechanisms. Am J Trop Med Hyg 83: 307–313. doi: 10.4269/ajtmh.2010.09-0617 20682873
12. Jacobsen KH, Padgett JJ, (2010) Risk factors for Mycobacterium ulcerans infection. Int J Infect Dis 14: e677–681. doi: 10.1016/j.ijid.2009.11.013 20185351
13. Bratschi MW, Ruf MT, Andreoli A, Minyem JC, Kerber S, et al. (2014) Mycobacterium ulcerans persistence at a village water source of Buruli ulcer patients. PLoS Negl Trop Dis 8: e2756. doi: 10.1371/journal.pntd.0002756 24675964
14. Silva MT, Portaels F, Pedrosa J, (2009) Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer. Lancet Infect Dis 9: 699–710. doi: 10.1016/S1473-3099(09)70234-8 19850228
15. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, et al. (2004) Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health 9: 1297–1304. 15598261
16. World Health Organization (2001) Buruli Ulcer. Diagnosis of Mycobacterium ulcerans disease. A manual for health care providers. WHO/CDS/GBUI/2001.4.
17. Lagarrigue V, Portaels F, Meyers WM, Aguiar J, (2000) [Buruli ulcer: risk of bone involvement! Apropos of 33 cases observed in Benin]. Med Trop (Mars) 60: 262–266.
18. Johnson RC, Nackers F, Glynn JR, de Biurrun Bakedano E, Zinsou C, et al. (2008) Association of HIV infection and Mycobacterium ulcerans disease in Benin. AIDS 22: 901–903. doi: 10.1097/QAD.0b013e3282f7690a 18427211
19. Christinet V, Comte E, Ciaffi L, Odermatt P, Serafini M, et al. (2015) Impact of human immunodeficiency virus on the severity of buruli ulcer disease: results of a retrospective study in cameroon. Open Forum Infect Dis 1: ofu021.
20. Pszolla N, Sarkar MR, Strecker W, Kern P, Kinzl L, et al. (2003) Buruli ulcer: a systemic disease. Clin Infect Dis 37: e78–82. 12955667
21. Ackumey MM, Gyapong M, Pappoe M, Maclean CK, Weiss MG, (2012) Socio-cultural determinants of timely and delayed treatment of Buruli ulcer: Implications for disease control. Infect Dis Poverty 1: 6. doi: 10.1186/2049-9957-1-6 23849228
22. Ackumey MM, Gyapong M, Pappoe M, Kwakye-Maclean C, Weiss MG, (2012) Illness meanings and experiences for pre-ulcer and ulcer conditions of Buruli ulcer in the Ga-West and Ga-South Municipalities of Ghana. BMC Public Health 12: 264. doi: 10.1186/1471-2458-12-264 22471884
23. Stienstra Y, van der Graaf WT, Asamoa K, van der Werf TS, (2002) Beliefs and attitudes toward Buruli ulcer in Ghana. Am J Trop Med Hyg 67: 207–213. 12389949
24. Nienhuis WA, Stienstra Y, Thompson WA, Awuah PC, Abass KM, et al. (2010) Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial. Lancet 375: 664–672. doi: 10.1016/S0140-6736(09)61962-0 20137805
25. Renzaho AM, Woods PV, Ackumey MM, Harvey SK, Kotin J, (2007) Community-based study on knowledge, attitude and practice on the mode of transmission, prevention and treatment of the Buruli ulcer in Ga West District, Ghana. Trop Med Int Health 12: 445–458. 17313516
26. Mulder AA, Boerma RP, Barogui Y, Zinsou C, Johnson RC, et al. (2008) Healthcare seeking behaviour for Buruli ulcer in Benin: a model to capture therapy choice of patients and healthy community members. Trans R Soc Trop Med Hyg 102: 912–920. doi: 10.1016/j.trstmh.2008.05.026 18617207
27. Merritt RW, Walker ED, Small PL, Wallace JR, Johnson PD, et al. (2010) Ecology and transmission of Buruli ulcer disease: a systematic review. PLoS Negl Trop Dis 4: e911. doi: 10.1371/journal.pntd.0000911 21179505
28. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers WM, et al. (2004) Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997–2001. Emerg Infect Dis 10: 1391–1398. 15496239
29. Vincent QB, Ardant MF, Adeye A, Goundote A, Saint-Andre JP, et al. (2014) Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study. Lancet Glob Health 2: e422–430. doi: 10.1016/S2214-109X(14)70223-2 25103396
30. World Health Organization (2012) Treatment of Mycobacterium ulcerans disease (Buruli ulcer): guidance for health workers.
31. Amofah G, Bonsu F, Tetteh C, Okrah J, Asamoa K, et al. (2002) Buruli ulcer in Ghana: results of a national case search. Emerg Infect Dis 8: 167–170. 11897068
32. Sopoh GE, Johnson RC, Chauty A, Dossou AD, Aguiar J, et al. (2007) Buruli ulcer surveillance, Benin, 2003–2005. Emerg Infect Dis 13: 1374–1376. doi: 10.3201/eid1309.061338 18252113
33. Kanga JM, Kacou ED, (2001) [Epidemiologicl aspects of Buruli ulcer in Cote d'Ivoire: results of a national survey]. Bull Soc Pathol Exot 94: 46–51. 11346983
34. Pak J, O'Brien DP, Quek T, Athan E, (2012) Treatment costs of Mycobacterium ulcerans in the antibiotic era. Int Health 4: 123–127. doi: 10.1016/j.inhe.2011.12.005 24029150
35. Jenkin GA, Smith M, Fairley M, Johnson PD, (2002) Acute, oedematous Mycobacterium ulcerans infection in a farmer from far north Queensland. Med J Aust 176: 180–181. 11915879
36. Trevillyan JM, Johnson PD, (2013) Steroids control paradoxical worsening of Mycobacterium ulcerans infection following initiation of antibiotic therapy. Med J Aust 198: 443–444. 23641997
37. Phanzu DM, Suykerbuyk P, Imposo DB, Lukanu PN, Minuku JB, et al. (2012) Effect of a control project on clinical profiles and outcomes in buruli ulcer: a before/after study in Bas-Congo, Democratic Republic of Congo. PLoS Negl Trop Dis 5: e1402.
38. Phanzu DM, Ablordey A, Imposo DB, Lefevre L, Mahema RL, et al. (2007) Short report: edematous Mycobacterium ulcerans infection (Buruli ulcer) on the face: a case report. Am J Trop Med Hyg 77: 1099–1102. 18165530
39. Marion E, Carolan K, Adeye A, Kempf M, Chauty A, et al. (2015) Buruli ulcer in South Western Nigeria: a retrospective cohort study of patients treated in Benin. PLoS Negl Trop Dis 9: e3443. doi: 10.1371/journal.pntd.0003443 25569775
40. Boyd SC, Athan E, Friedman ND, Hughes A, Walton A, et al. (2012) Epidemiology, clinical features and diagnosis of Mycobacterium ulcerans in an Australian population. Med J Aust 196: 341–344. 22432674
41. O'Brien DP, Friedman ND, McDonald A, Callan P, Hughes A, et al. (2014) Clinical features and risk factors of oedematous Mycobacterium ulcerans lesions in an Australian population: beware cellulitis in an endemic area. PLoS Negl Trop Dis 8: e2612. doi: 10.1371/journal.pntd.0002612 24392172
42. Johnson RC, Sopoh GE, Boko M, Zinsou C, Gbovi J, et al. (2005) [Distribution of Mycobacterium ulcerans (Buruli ulcer) in the district of Lalo in Benin.]. Trop Med Int Health 10: 863–871. 16135193
43. Bretzel G, Huber KL, Kobara B, Beissner M, Piten E, et al. (2011) Laboratory confirmation of Buruli ulcer disease in Togo, 2007–2010. PLoS Negl Trop Dis 5: e1228. doi: 10.1371/journal.pntd.0001228 21811641
44. Porten K, Sailor K, Comte E, Njikap A, Sobry A, et al. (2009) Prevalence of Buruli ulcer in Akonolinga health district, Cameroon: results of a cross sectional survey. PLoS Negl Trop Dis 3: e466. doi: 10.1371/journal.pntd.0000466 19547747
45. Noeske J, Kuaban C, Rondini S, Sorlin P, Ciaffi L, et al. (2004) Buruli ulcer disease in Cameroon rediscovered. Am J Trop Med Hyg 70: 520–526. 15155984
46. Ouattara D, Meningaud JP, Saliba F, (2002) [Multifocal forms of Buruli ulcer: clinical aspects and management difficulties in 11 cases]. Bull Soc Pathol Exot 95: 287–291. 12596381
47. James K, Attipou KK, James YE, Blakime M, Tignokpa N, et al. (2003) [Buruli ulcer in Togo: a hospital study]. Sante 13: 43–47. 12925323
48. Mavinga Phanzu D, Suykerbuyk P, Saunderson P, Ngwala Lukanu P, Masamba Minuku JB, et al. (2013) Burden of Mycobacterium ulcerans disease (Buruli ulcer) and the underreporting ratio in the territory of Songololo, Democratic Republic of Congo. PLoS Negl Trop Dis 7: e2563. doi: 10.1371/journal.pntd.0002563 24340112
49. Phanzu DM, Mahema RL, Suykerbuyk P, Imposo DH, Lehman LF, et al. (2011) Mycobacterium ulcerans infection (Buruli ulcer) on the face: a comparative analysis of 13 clinically suspected cases from the Democratic Republic of Congo. Am J Trop Med Hyg 85: 1100–1105. doi: 10.4269/ajtmh.2011.10-0530 22144452
50. Quek TY, Henry MJ, Pasco JA, O'Brien DP, Johnson PD, et al. (2007) Mycobacterium ulcerans infection: factors influencing diagnostic delay. Med J Aust 187: 561–563. 18021043
51. Guerra H, Palomino JC, Falconi E, Bravo F, Donaires N, et al. (2008) Mycobacterium ulcerans disease, Peru. Emerg Infect Dis 14: 373–377. doi: 10.3201/eid1403.070904 18325248